A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma Kumar, A., Casulo, C., Advani, R. H., Budde, L. E., Barr, P. M., Batlevi, C., Caron, P., Constine, L. S., Dandapani, S., Drill, E., Drullinsky, P., Friedberg, J. W., Grieve, C., Hamilton, A., Hamlin, P. A., Hoppe, R. T., Horwitz, S. M., Matasar, M. J., McCall, S., Moskowitz, A. J., Noy, A., Palomba, M., Schoder, H., Straus, D. J., Vemuri, S., Yang, J. C., Younes, A., Zelenetz, A. D., Yahalom, J., Moskowitz, C. H. AMER SOC HEMATOLOGY. 2019

View details for DOI 10.1182/blood-2019-123150

View details for Web of Science ID 000577160406215